AHA GUIDELINES Bundle (free trial)

Acute Ischemic Stroke - Early Management

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/222939

Contents of this Issue

Navigation

Page 18 of 29

17 Endovascular Interventions Î Patients eligible for IV rtPA should receive IV rtPA even if endovascular treatments are being considered (I-A). (Unchanged from 2013 guideline) Î Patients should receive endovascular therapy with a stent retriever if they meet all the following criteria (I-A) (New recommendation): • pre-stroke modified Rankin score (mRS) 0-1acute ischemic stroke receiving IV rtPA within 4.5 hours of onset according to guidelines from professional medical societies • causative occlusion of the internal carotid artery or proximal middle cerebral artery (M1) • age 18 years and over • National Institutes of Health Stroke Scale (NIHSS) score of ≥6 • Alberta Stroke Program Early Computed Tomography Score (ASPECTS) of 6 or greater, and • treatment can be initiated (groin puncture) within 6 hours of symptom onset Î As with IV rtPA, reduced time from symptom onset to reperfusion with endovascular therapies is highly associated with better clinical outcomes. To ensure benefit, reperfusion to TICI grade 2b/3 should be achieved as early as possible and within 6 hours of stroke onset (I-B-R). (Revised from 2013 guideline) Î When treatment is initiated beyond 6 hours from symptom onset, the benefits of endovascular therapy are uncertain for patients with acute ischemic stroke who have causative occlusion of the internal carotid artery or proximal middle cerebral artery (M1) (IIb-C). (New recommendation from 2013 guideline) Note: Additional randomized trial data are needed. Î In carefully selected patients with anterior circulation occlusion who have contraindications to IV rtPA, endovascular therapy with stent retrievers completed within 6 hours of stroke onset is reasonable (IIa-C). (New recommendation from 2013 guideline) Note: There are inadequate data available at this time to determine the clinical efficacy of endovascular therapy with stent retrievers for those patients whose contraindications are time-based or non-time based (such as prior stroke, serious head trauma, hemorrhagic coagulopathy or receiving anticoagulant medications). Î Although the benefits are uncertain, use of endovascular therapy with stent retrievers may be reasonable for carefully selected patients with acute ischemic stroke in whom treatment can be initiated (groin puncture) within 6 hours of symptom onset and who have causative occlusion of the M2 or M3 portion of the middle cerebral arteries, anterior cerebral arteries, vertebral arteries, basilar artery or posterior cerebral arteries (IIb-C). (New recommendation from 2013 guideline)

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Acute Ischemic Stroke - Early Management